Immune response after two doses of the BNT162b2 COVID-19 vaccine and risk of SARS-CoV-2 breakthrough infection in Tyrol, Austria: an open-label, observational phase 4 trial-Reference-Cited by-同舟云学术

Immune response after two doses of the BNT162b2 COVID-19 vaccine and risk of SARS-CoV-2 breakthrough infection in Tyrol, Austria: an open-label, observational phase 4 trial

Published:2023-08 Issue:8 Volume:4 Page:e612-e621
ISSN:2666-5247
Container-title:The Lancet Microbe
language:en
Short-container-title:The Lancet Microbe

Author:

Seekircher Lisa,Bánki Zoltán,Kimpel Janine,Rössler Annika,Schäfer Helena,Falkensammer Barbara,Bante David,Forer Lukas,Schönherr Sebastian,Harthaller Teresa,Sacher Magdalena,Ower Cornelia,Tschiderer Lena,Ulmer Hanno,Krammer Florian,von Laer Dorothee,Borena Wegene,Willeit Peter,Bánki Zoltán,Kimpel Janine,Rössler Annika,Schäfer Helena,Falkensammer Barbara,Bante David,Krammer Florian,von Laer Dorothee,Borena Wegene,Forer Lukas,Schönherr Sebastian,Sacher Magdalena,Ower Cornelia,Harthaller Teresa,Neurauter Bianca,Hochmuth Eva,Hoch Luiza,Huber Maria,Müllauer Brigitte,Peer Evelyn,Raschbichler Lisa-Maria,Falch Albert,Embacher-Aichhorn Sabine,Becker Kathrin,Seekircher Lisa,Tschiderer Lena,Ulmer Hanno,Willeit Peter

Funder

Medizinische Universität Innsbruck

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Reference30 articles.

1. Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection;Feng;Nat Med,2021

2. Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial;Gilbert;Science,2022

3. SARS-CoV-2 antibodies and breakthrough infections in the Virus Watch cohort;Aldridge;Nat Commun,2022

4. Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines;Wei;Nat Med,2022

5. Levels of SARS-CoV-2 antibodies among fully vaccinated individuals with delta or omicron variant breakthrough infections;Stærke;Nat Commun,2022

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti‐Spike IgG antibodies as correlates of protection against SARS‐CoV‐2 infection in the pre‐Omicron and Omicron era;Journal of Medical Virology;2024-08

2. Development of Next-Generation COVID-19 Vaccines: Biomedical Advanced Research and Development Authority (BARDA)–Supported Phase 2b Study Designs;Clinical Infectious Diseases;2024-05-28

3. High Transferability of Neutralizing Antibodies against SARS-CoV-2 to Umbilical Cord Blood in Pregnant Women Vaccinated with BNT162b2 XBB.1.5: A Retrospective Cohort Study;Infectious Disease Reports;2024-05-27

4. Cellular Immunity of SARS-CoV-2 in the Borriana COVID-19 Cohort: A Nested Case–Control Study;Epidemiologia;2024-04-10

5. Anti-SARS-CoV-2 IgG Seroprevalence in Tyrol, Austria, among 28,768 Blood Donors between May 2022 and March 2023;Vaccines;2024-03-08